A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.
Professor James Paton, Director of the University of Adelaide’s Research Centre for Infectious Diseases and his team have been working on a vaccine for Streptococcus pneumoniae (the pneumococcus) that could save two million lives globally a year and address the overuse of antibiotics that leads to resistance.
“The pneumococcus is the biggest bacterial killer on the planet. It’s the most common cause of pneumonia, which is responsible for about 20 per cent of deaths from all causes in children under 5 years in developing countries. Globally, the pneumococcus accounts for about two million deaths a year,” says Professor Paton.
Streptococcus pneumoniae, which is principally spread through close contact with infected but asymptomatic carriers, is the leading cause of sinus and ear infections, meningitis, sepsis and pneumonia. Ear infections are one of the most common childhood illnesses that are habitually treated with antibiotics, contributing to increasing bacterial resistance.
“Vaccinating people against Streptococcus pneumoniae would help to ameliorate the global challenge of increasing bacterial resistance to antibiotics,” says Professor Paton.
“The problem with the existing pneumococcal vaccine is that it targets the outside coat of complex carbohydrates – of which there are 98 structurally distinct types. The current vaccine costs about $150 a dose and only covers 13 types.
“What we have done is to remove this coat to expose all the surface proteins that are common to all pneumococcal types. The body mounts an immune response to these surface proteins if previously exposed or vaccinated.”
Sixteen months ago, Adelaide-based GPN Vaccines Pty Ltd was created to develop this novel “whole bacterial” vaccine (Gamma-PNTM) against Streptococcus pneumoniae. The company has already secured investment from local angel investors as well as a major grant from the National Health & Medical Research Council and a Commercialisation grant from the South Australian Government.
GPN Vaccines has now raised a further AUS$1.1 million from international and Australian-based investors that will be used for preclinical evaluation of the Gamma-PNTM vaccine. Toxicity tests will be carried out as well as the scale-up clinical grade manufacture of the vaccine in readiness for testing in a first-in-human clinical trial.
Learn more: STEP FORWARD FOR PNEUMONIA VACCINE DEVELOPMENT
The Latest on: Pneumonia
via Google News
The Latest on: Pneumonia
- AP Explains: the Virus Behind China's Pneumonia Outbreakon January 9, 2020 at 1:01 pm
Scientists have a preliminary suspect in a mysterious viral pneumonia infecting people in the central Chinese city of Wuhan: coronavirus.
- China's mystery pneumonia outbreak blamed on new SARS-type viruson January 9, 2020 at 11:39 am
With a massive holiday travel rush looming, officials are still racing to figure out the source of the illness, how it's spread and how to stop it.
- Mysterious viral pneumonia outbreak in China likely caused by new virus, scientists sayon January 9, 2020 at 8:35 am
Scientists in China who are researching an outbreak of viral pneumonia that’s sickened dozens in the city of Wuhan have identified a new type of coronavirus as the likely culprit behind the illnesses, ...
- Wuhan pneumonia outbreak in China blamed on new SARS-type viruson January 9, 2020 at 6:39 am
Beijing — China believes a mysterious pneumonia outbreak that struck 59 people is caused by a new strain of virus from the same family as SARS, which killed hundreds of people more than a decade ago.
- How China’s Mystery Pneumonia Illness is Different From SARSon January 9, 2020 at 6:28 am
A mysterious outbreak of pneumonia in central China that has been causing alarm has been linked to a new coronavirus, a family of bugs responsible for diseases that range in severity from the common ...
- Morning Break: RBG 'Cancer-Free'; Alert on Wuhan Pneumonia; Don't Call Me Med Studenton January 9, 2020 at 6:04 am
Hundreds of Seattle public school students were locked out for failing to produce vaccination records. (Seattle Times) The CDC activated its Health Alert Network to advise state and local officials on ...
- Wuhan pneumonia outbreak: Mystery illness 'caused by coronavirus'on January 9, 2020 at 3:44 am
Scientists believe they may have found the cause of the mystery pneumonia that has infected almost 60 people in the Chinese city of Wuhan since December. Preliminary tests indicated the illness may be ...
- New SARS related virus, Wuhan pneumonia, idenitified in China's mysterious pneumonia outbreakon January 9, 2020 at 2:38 am
A mysterious pneumonia outbreak that has struck dozens of people and put China on edge is from the same family of viruses as the deadly severe acute respiratory syndrome (SARS), according to Chinese ...
- New virus fueling China Pneumonia outbreakon January 9, 2020 at 2:35 am
VP Pence Exclusive Interview Trump Responds To Iran Iran Attacks Military Bases Impeachment Trial Rules RBG Cancer Update Australia Fires Harry & Meghan Step Back News US World Politics Entertainment ...
- AP Explains: The pathogen behind China's pneumonia outbreakon January 9, 2020 at 1:56 am
BEIJING -- Since late last year, people in the central Chinese city of Wuhan have been infected with a viral pneumonia whose cause was unknown. The outbreak raised the specter of another SARS epidemic ...
via Bing News